The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Dydrogesterone Drug Market Outlook 2024
Synopsis
Dydrogesterone is a progestin medication, which used for a variety of indications, including threatened or recurrent miscarriage during pregnancy, dysfunctional bleeding, infertility due to luteal insufficiency, dysmenorrhea, endometriosis, secondary amenorrhea, irregular cycles, premenstrual syndrome, and as a component of menopausal hormone therapy. It is taken by mouth.
The classification of Dydrogesterone Drug includes Dydrogesterone and Dydrogesterone +Estradiol Compound, and the sale proportion of Dydrogesterone in 2019 is about 75.22%.
Dydrogesterone Drug is widely used for Infertility, Gynecological Diseases, Threatened Abortion, etc. The most proportion of Dydrogesterone Drug is used for Infertility, and the proportion in 2019 is 67.71%.
There are mainly two manufacturers in this industry, which is Abbott and Viatris，and their production are in Europe and USA respectively.
Asia-Pacific is the largest consumption place, with a consumption market share nearly 62.27% in 2019. Following Asia-Pacific, Europe is the second largest consumption place with the consumption market share of 15.77%.
The global Dydrogesterone Drug market was valued at US$ 542.9 million in 2020 and is expected to reach US$ 1037.9 million by the end of 2027, growing at a CAGR of 9.7% during 2021-2027.
This report focuses on Dydrogesterone Drug volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Dydrogesterone Drug market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Dydrogesterone Drug Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Dydrogesterone
Dydrogesterone+Estradiol Compound
Segment by Application
Infertility
Gynecological Diseases
Threatened Abortion
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Abbott
Viatris
Dydrogesterone is a progestin medication, which used for a variety of indications, including threatened or recurrent miscarriage during pregnancy, dysfunctional bleeding, infertility due to luteal insufficiency, dysmenorrhea, endometriosis, secondary amenorrhea, irregular cycles, premenstrual syndrome, and as a component of menopausal hormone therapy. It is taken by mouth.
The classification of Dydrogesterone Drug includes Dydrogesterone and Dydrogesterone +Estradiol Compound, and the sale proportion of Dydrogesterone in 2019 is about 75.22%.
Dydrogesterone Drug is widely used for Infertility, Gynecological Diseases, Threatened Abortion, etc. The most proportion of Dydrogesterone Drug is used for Infertility, and the proportion in 2019 is 67.71%.
There are mainly two manufacturers in this industry, which is Abbott and Viatris，and their production are in Europe and USA respectively.
Asia-Pacific is the largest consumption place, with a consumption market share nearly 62.27% in 2019. Following Asia-Pacific, Europe is the second largest consumption place with the consumption market share of 15.77%.
The global Dydrogesterone Drug market was valued at US$ 542.9 million in 2020 and is expected to reach US$ 1037.9 million by the end of 2027, growing at a CAGR of 9.7% during 2021-2027.
This report focuses on Dydrogesterone Drug volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Dydrogesterone Drug market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.
Global Dydrogesterone Drug Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
Segment by Type
Dydrogesterone
Dydrogesterone+Estradiol Compound
Segment by Application
Infertility
Gynecological Diseases
Threatened Abortion
Other
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
By Company
Abbott
Viatris
Index1 Dydrogesterone Drug Market Overview
1.1 Product Overview and Scope of Dydrogesterone Drug
1.2 Dydrogesterone Drug Segment by Type
1.2.1 Global Dydrogesterone Drug Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Dydrogesterone
1.2.3 Dydrogesterone+Estradiol Compound
1.3 Dydrogesterone Drug Segment by Application
1.3.1 Global Dydrogesterone Drug Sales Comparison by Application: (2021-2027)
1.3.2 Infertility
1.3.3 Gynecological Diseases
1.3.4 Threatened Abortion
1.3.5 Other
1.4 Global Dydrogesterone Drug Market Size Estimates and Forecasts
1.4.1 Global Dydrogesterone Drug Revenue 2016-2027
1.4.2 Global Dydrogesterone Drug Sales 2016-2027
1.4.3 Dydrogesterone Drug Market Size by Region: 2016 Versus 2021 Versus 2027
2 Dydrogesterone Drug Market Competition by Manufacturers
2.1 Global Dydrogesterone Drug Sales Market Share by Manufacturers (2016-2021)
2.2 Global Dydrogesterone Drug Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Dydrogesterone Drug Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Dydrogesterone Drug Manufacturing Sites, Area Served, Product Type
2.5 Dydrogesterone Drug Market Competitive Situation and Trends
2.5.1 Dydrogesterone Drug Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Dydrogesterone Drug Players Market Share by Revenue
2.5.3 Global Dydrogesterone Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Dydrogesterone Drug Retrospective Market Scenario by Region
3.1 Global Dydrogesterone Drug Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Dydrogesterone Drug Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Dydrogesterone Drug Market Facts & Figures by Country
3.3.1 North America Dydrogesterone Drug Sales by Country
3.3.2 North America Dydrogesterone Drug Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Dydrogesterone Drug Market Facts & Figures by Country
3.4.1 Europe Dydrogesterone Drug Sales by Country
3.4.2 Europe Dydrogesterone Drug Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Dydrogesterone Drug Market Facts & Figures by Region
3.5.1 Asia Pacific Dydrogesterone Drug Sales by Region
3.5.2 Asia Pacific Dydrogesterone Drug Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Dydrogesterone Drug Market Facts & Figures by Country
3.6.1 Latin America Dydrogesterone Drug Sales by Country
3.6.2 Latin America Dydrogesterone Drug Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Dydrogesterone Drug Market Facts & Figures by Country
3.7.1 Middle East and Africa Dydrogesterone Drug Sales by Country
3.7.2 Middle East and Africa Dydrogesterone Drug Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Dydrogesterone Drug Historic Market Analysis by Type
4.1 Global Dydrogesterone Drug Sales Market Share by Type (2016-2021)
4.2 Global Dydrogesterone Drug Revenue Market Share by Type (2016-2021)
4.3 Global Dydrogesterone Drug Price by Type (2016-2021)
5 Global Dydrogesterone Drug Historic Market Analysis by Application
5.1 Global Dydrogesterone Drug Sales Market Share by Application (2016-2021)
5.2 Global Dydrogesterone Drug Revenue Market Share by Application (2016-2021)
5.3 Global Dydrogesterone Drug Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Abbott
6.1.1 Abbott Corporation Information
6.1.2 Abbott Description and Business Overview
6.1.3 Abbott Dydrogesterone Drug Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Abbott Dydrogesterone Drug Product Portfolio
6.1.5 Abbott Recent Developments/Updates
6.2 Viatris
6.2.1 Viatris Corporation Information
6.2.2 Viatris Description and Business Overview
6.2.3 Viatris Dydrogesterone Drug Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Viatris Dydrogesterone Drug Product Portfolio
6.2.5 Viatris Recent Developments/Updates
7 Dydrogesterone Drug Manufacturing Cost Analysis
7.1 Dydrogesterone Drug Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Dydrogesterone Drug
7.4 Dydrogesterone Drug Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Dydrogesterone Drug Distributors List
8.3 Dydrogesterone Drug Customers
9 Dydrogesterone Drug Market Dynamics
9.1 Dydrogesterone Drug Industry Trends
9.2 Dydrogesterone Drug Growth Drivers
9.3 Dydrogesterone Drug Market Challenges
9.4 Dydrogesterone Drug Market Restraints
10 Global Market Forecast
10.1 Dydrogesterone Drug Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Dydrogesterone Drug by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Dydrogesterone Drug by Type (2022-2027)
10.2 Dydrogesterone Drug Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Dydrogesterone Drug by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Dydrogesterone Drug by Application (2022-2027)
10.3 Dydrogesterone Drug Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Dydrogesterone Drug by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Dydrogesterone Drug by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of TablesList of Tables
Table 1. Global Dydrogesterone Drug Sales (Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Dydrogesterone Drug Sales (Units) Comparison by Application (2021-2027)
Table 3. Global Dydrogesterone Drug Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Dydrogesterone Drug Covered in This Study
Table 5. Global Dydrogesterone Drug Sales (Units) of Key Manufacturers (2016-2021)
Table 6. Global Dydrogesterone Drug Sales Market Share by Manufacturers (2016-2021)
Table 7. Global Dydrogesterone Drug Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Dydrogesterone Drug Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Dydrogesterone Drug Average Price (USD/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Dydrogesterone Drug Manufacturing Sites and Area Served
Table 11. Manufacturers Dydrogesterone Drug Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Dydrogesterone Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Dydrogesterone Drug as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Dydrogesterone Drug Sales by Region (2016-2021) & (Units)
Table 16. Global Dydrogesterone Drug Sales Market Share by Region (2016-2021)
Table 17. Global Dydrogesterone Drug Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Dydrogesterone Drug Sales by Country (2016-2021) & (Units)
Table 19. North America Dydrogesterone Drug Sales Market Share by Country (2016-2021)
Table 20. North America Dydrogesterone Drug Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Dydrogesterone Drug Revenue Market Share by Country (2016-2021)
Table 22. Europe Dydrogesterone Drug Sales by Country (2016-2021) & (Units)
Table 23. Europe Dydrogesterone Drug Sales Market Share by Country (2016-2021)
Table 24. Europe Dydrogesterone Drug Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Dydrogesterone Drug Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Dydrogesterone Drug Sales by Region (2016-2021) & (Units)
Table 27. Asia Pacific Dydrogesterone Drug Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Dydrogesterone Drug Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Dydrogesterone Drug Revenue Market Share by Region (2016-2021)
Table 30. Latin America Dydrogesterone Drug Sales by Country (2016-2021) & (Units)
Table 31. Latin America Dydrogesterone Drug Sales Market Share by Country (2016-2021)
Table 32. Latin America Dydrogesterone Drug Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Dydrogesterone Drug Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Dydrogesterone Drug Sales by Country (2016-2021) & (Units)
Table 35. Middle East and Africa Dydrogesterone Drug Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Dydrogesterone Drug Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Dydrogesterone Drug Revenue Market Share by Country (2016-2021)
Table 38. Global Dydrogesterone Drug Sales (Units) by Type (2016-2021)
Table 39. Global Dydrogesterone Drug Sales Market Share by Type (2016-2021)
Table 40. Global Dydrogesterone Drug Revenue (Million US$) by Type (2016-2021)
Table 41. Global Dydrogesterone Drug Revenue Share by Type (2016-2021)
Table 42. Global Dydrogesterone Drug Price (USD/Unit) by Type (2016-2021)
Table 43. Global Dydrogesterone Drug Sales (Units) by Application (2016-2021)
Table 44. Global Dydrogesterone Drug Sales Market Share by Application (2016-2021)
Table 45. Global Dydrogesterone Drug Revenue (Million US$) by Application (2016-2021)
Table 46. Global Dydrogesterone Drug Revenue Share by Application (2016-2021)
Table 47. Global Dydrogesterone Drug Price (USD/Unit) by Application (2016-2021)
Table 48. Abbott Corporation Information
Table 49. Abbott Description and Business Overview
Table 50. Abbott Dydrogesterone Drug Sales (Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 51. Abbott Dydrogesterone Drug Product
Table 52. Abbott Recent Developments/Updates
Table 53. Viatris Corporation Information
Table 54. Viatris Description and Business Overview
Table 55. Viatris Dydrogesterone Drug Sales (Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2021)
Table 56. Viatris Dydrogesterone Drug Product
Table 57. Viatris Recent Developments/Updates
Table 58. Production Base and Market Concentration Rate of Raw Material
Table 59. Key Suppliers of Raw Materials
Table 60. Dydrogesterone Drug Distributors List
Table 61. Dydrogesterone Drug Customers List
Table 62. Dydrogesterone Drug Market Trends
Table 63. Dydrogesterone Drug Growth Drivers
Table 64. Dydrogesterone Drug Market Challenges
Table 65. Dydrogesterone Drug Market Restraints
Table 66. Global Dydrogesterone Drug Sales Forecast by Type (2022-2027) & (Units)
Table 67. Global Dydrogesterone Drug Sales Market Share Forecast by Type (2022-2027)
Table 68. Global Dydrogesterone Drug Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 69. Global Dydrogesterone Drug Revenue Market Share Forecast by Type (2022-2027)
Table 70. Global Dydrogesterone Drug Sales Forecast by Application (2022-2027) & (Units)
Table 71. Global Dydrogesterone Drug Sales Market Share Forecast by Application (2022-2027)
Table 72. Global Dydrogesterone Drug Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 73. Global Dydrogesterone Drug Revenue Market Share Forecast by Application (2022-2027)
Table 74. Global Dydrogesterone Drug Sales Forecast by Region (2022-2027) & (Units)
Table 75. Global Dydrogesterone Drug Sales Market Share Forecast by Region (2022-2027)
Table 76. Global Dydrogesterone Drug Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 77. Global Dydrogesterone Drug Revenue Market Share Forecast by Region (2022-2027)
Table 78. Research Programs/Design for This Report
Table 79. Key Data Information from Secondary Sources
Table 80. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Dydrogesterone Drug
Figure 2. Global Dydrogesterone Drug Market Share by Type in 2020 & 2027
Figure 3. Dydrogesterone Product Picture
Figure 4. Dydrogesterone+Estradiol Compound Product Picture
Figure 5. Global Dydrogesterone Drug Market Share by Application in 2020 & 2027
Figure 6. Infertility
Figure 7. Gynecological Diseases
Figure 8. Threatened Abortion
Figure 9. Other
Figure 10. Global Dydrogesterone Drug Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Dydrogesterone Drug Market Size 2016-2027 (US$ Million)
Figure 12. Global Dydrogesterone Drug Sales 2016-2027 (Units)
Figure 13. Global Dydrogesterone Drug Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 14. Dydrogesterone Drug Sales Share by Manufacturers in 2020
Figure 15. Global Dydrogesterone Drug Revenue Share by Manufacturers in 2020
Figure 16. The Global 5 and 10 Largest Dydrogesterone Drug Players: Market Share by Revenue in 2020
Figure 17. Dydrogesterone Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 18. Global Dydrogesterone Drug Sales Market Share by Region (2016-2021)
Figure 19. Global Dydrogesterone Drug Sales Market Share by Region in 2020
Figure 20. Global Dydrogesterone Drug Revenue Market Share by Region (2016-2021)
Figure 21. Global Dydrogesterone Drug Revenue Market Share by Region in 2020
Figure 22. U.S. Dydrogesterone Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Canada Dydrogesterone Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Germany Dydrogesterone Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. France Dydrogesterone Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. U.K. Dydrogesterone Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Italy Dydrogesterone Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Russia Dydrogesterone Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. China Dydrogesterone Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Japan Dydrogesterone Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. South Korea Dydrogesterone Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. India Dydrogesterone Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Australia Dydrogesterone Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Taiwan Dydrogesterone Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Indonesia Dydrogesterone Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Thailand Dydrogesterone Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Malaysia Dydrogesterone Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Mexico Dydrogesterone Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Brazil Dydrogesterone Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Argentina Dydrogesterone Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Turkey Dydrogesterone Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Saudi Arabia Dydrogesterone Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. UAE Dydrogesterone Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Sales Market Share of Dydrogesterone Drug by Type (2016-2021)
Figure 45. Sales Market Share of Dydrogesterone Drug by Application (2016-2021)
Figure 46. Sales Market Share of Dydrogesterone Drug by Application in 2020
Figure 47. Revenue Share of Dydrogesterone Drug by Application (2016-2021)
Figure 48. Revenue Share of Dydrogesterone Drug by Application in 2020
Figure 49. Manufacturing Cost Structure of Dydrogesterone Drug
Figure 50. Manufacturing Process Analysis of Dydrogesterone Drug
Figure 51. Dydrogesterone Drug Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
